UFT (uracil, tegafur)
Sponsors
Taiho Pharmaceutical Co., Ltd.
Conditions
Breast CancerColorectal CancerGastric Cancer
Phase 3
A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)
CompletedNCT00152191
Start: 1996-10-31End: 2008-01-31Target: 1300Updated: 2011-07-07
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)
CompletedNCT00152243
Start: 1997-06-30End: 2007-08-31Target: 500Updated: 2011-07-07
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)
CompletedNCT00152230
Start: 1996-10-31End: 2008-02-29Target: 900Updated: 2011-07-07